Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Science, medicine and clinical pharmacology. The Lilly Lecture 1994.

Literature DB >> 8527257

Science, medicine and clinical pharmacology. The Lilly Lecture 1994.

A Breckenridge¹.

Abstract

Mesh：

Year: 1995 PMID： 8527257 PMCID： PMC1365020 DOI： 10.1111/j.1365-2125.1995.tb04527.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

28 in total

1. Innovation in the pharmaceutical industry.

Authors: R Sykes
Journal: BMJ Date: 1994-08-13

2. Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria.

Authors: C S Hatton; T E Peto; C Bunch; G Pasvol; S J Russell; C R Singer; G Edwards; P Winstanley
Journal: Lancet Date: 1986-02-22 Impact factor: 79.321

3. 3'-Azido-3'-deoxythymidine potently inhibits protein glycosylation. A novel mechanism for AZT cytotoxicity.

Authors: E T Hall; J P Yan; P Melançon; R D Kuchta
Journal: J Biol Chem Date: 1994-05-20 Impact factor: 5.157

4. Correlates of zidovudine phosphorylation with markers of HIV disease progression and drug toxicity.

Authors: B N Stretcher; A J Pesce; P T Frame; K A Greenberg; D S Stein
Journal: AIDS Date: 1994-06 Impact factor: 4.177

Review 5. The role of active metabolites in drug toxicity.

Authors: M Pirmohamed; N R Kitteringham; B K Park
Journal: Drug Saf Date: 1994-08 Impact factor: 5.606

6. Death and blindness due to overdose of quinine.

Authors: E H Dyson; A T Proudfoot; L F Prescott; R Heyworth
Journal: Br Med J (Clin Res Ed) Date: 1985-07-06

7. The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group.

Authors: P A Volberding; S W Lagakos; J M Grimes; D S Stein; H H Balfour; R C Reichman; J A Bartlett; M S Hirsch; J P Phair; R T Mitsuyasu
Journal: JAMA Date: 1994-08-10 Impact factor: 56.272

Science, medicine and clinical pharmacology. The Lilly Lecture 1994.

1. Innovation in the pharmaceutical industry.

2. Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria.

3. 3'-Azido-3'-deoxythymidine potently inhibits protein glycosylation. A novel mechanism for AZT cytotoxicity.

4. Correlates of zidovudine phosphorylation with markers of HIV disease progression and drug toxicity.

Review 5. The role of active metabolites in drug toxicity.

6. Death and blindness due to overdose of quinine.

7. The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group.

8. Zidovudine phosphorylation in HIV-infected patients and seronegative volunteers.

Review 9. Clinical pharmacokinetics in the treatment of tropical diseases. Some applications and limitations.

10. Pharmacokinetics of quinine in children.

Review 1. Adverse drug reactions: back to the future.